Cryo Cell International (CCEL) EPS (Basic) (2010 - 2026)

Cryo Cell International has disclosed EPS (Basic) across 17 years of filings, most recently posting $0.32 for Q1 2026.

• In Q1 2026, EPS (Basic) fell 83.35% year-over-year to $0.32; the TTM figure through Feb 2026 stood at -$17.91 (down 2169.62% YoY), while the FY2025 annual figure was -$16.33, down 703.88% from the prior year.
• EPS (Basic) grew to $0.32 in Q1 2026, from -$25.66 in the prior quarter.
• Over the last five years, EPS (Basic) for CCEL reached as high as $7.08 in Q3 2024 and fell as low as -$75.36 in Q4 2023.
• The 5-year median for EPS (Basic) is $3.75 (2024), against an average of -$3.45.
• Annual changes were most pronounced in 2023 — EPS (Basic) tumbled 1435.5% — and 2024, when it soared 196.75%.
• A 5-year view of EPS (Basic) shows it stood at $5.64 in 2022, then plunged by 1435.5% to -$75.36 in 2023, then jumped by 83.39% to -$12.52 in 2024, then sank by 104.96% to -$25.66 in 2025, then jumped by 101.23% to $0.32 in 2026.
• According to Business Quant data, EPS (Basic) over the past three periods registered $0.32, -$25.66, and $5.04 for Q1 2026, Q4 2025, and Q3 2025 respectively.